Core Insights - The concept of "home nebulization" is gaining traction in daily life due to the high prevalence of respiratory allergies and dry eye conditions, with 70% of people improperly administering eye drops, leading to reduced absorption rates [1] - The company "Wuyi Xi" has developed a series of nebulization devices targeting various body parts, aiming to replace traditional methods of medication administration [1][3] - The "Eye Care Treasure" nebulization device releases small molecular particles for effective treatment, containing ingredients like ergothioneine, lutein, and ginsenoside [1][3] Sales and Financial Projections - The nebulization series achieved over 100 million yuan in sales within a year through platforms like Douyin and offline pharmacies, with projected sales of 300 million yuan by 2025 [3] - The company has not sought external financing since its establishment over four years ago, indicating a focus on validating its products, technology, and marketing channels [3] Technical Challenges and Innovations - The company faces significant technical challenges in miniaturizing nebulization devices and preventing clogging of nebulization heads, which is a common issue in the industry [4] - Advanced technologies such as picosecond laser drilling and electro-polishing are employed to create smoother nebulization holes, reducing the risk of clogging [4] - The company aims to nebulize multiple components, which presents unique formulation challenges, such as solubilizing lipophilic substances like lutein and enhancing the permeability of hyaluronic acid [4] Marketing and Brand Strategy - Brand building and marketing capabilities are crucial for consumer products, with the company focusing on interest-based e-commerce for efficient user conversion [5] - The company has established partnerships with 20,000 pharmacies across 13 key cities and plans to expand into e-commerce platforms like Tmall and JD [5] - The strategy includes leveraging successful campaigns on Douyin to enhance brand value and replicate successful tactics in less competitive international markets [5][6] Future Outlook - The company is preparing for a Pre-A round of financing to strengthen its market position and deepen technical barriers while enhancing brand image [3][6] - The CEO emphasizes the importance of maintaining core strategies and execution integrity as the company seeks to scale its operations [6]

在 2025全球眼科大会的 聚光 灯下，雾以希展台前始终簇拥着各国医疗专家。他们反复端详着那台仅 口 红 大小的 "小睛灵护眼宝"，试图理解这个中国企业如何将专业雾化设备浓缩进随身装备。 记者在会议室见到徐亿时，他正用设备进行午间护眼， "这就是我们定义的未来——医疗级雾化护理应该 像使用手机一样自然。" # 万 亿市场 的 场 景 破 壁 后疫情时代的健康焦虑与技术进步正在重构 雾化 医疗产业格局。 "呼吸疾病高发遇上雾化技术普及，这仅 是变革的起点。" 徐亿 在展示相关检测数据时强调 ， "真正引爆市场的，是现代人日均8小时的屏幕使用与 工业化进程的 加快 —— 它们催生的眼疾、鼻炎等新慢病，正在打开治疗、预防 及养护 的 万 亿级市场。 " " 当行业聚焦医院场景时，雾以希已通过微型化技术将雾化设备融入生活全场景 。 " 徐亿在讲台上 用产 品迭代轨迹诠释着战略布局 。 记者发现，其产品定义中贯穿着 "移动式 雾化解决方案 "的理念——从 差旅 途中的眼部舒缓到办公间隙 的鼻腔护理，从居家环境下的呼吸道养护到 会议演讲时 的 口腔护理 ， 雾以希的 移动 式雾化设备正以 小巧便携的 体积承载全天候健康解 ...